Welcome!
Strategic Plan On The Development of Traditional Chinese Medicine (2016-30)
Broker's Calls
'Buy' Tianjin Zhong Xin as TCM demand could rebound strongly: UOB Kay Hian
Despite the impact from the novel coronavirus (Covid-19) lockdown measures, UOB KayHian is still bullish on Tianjin Zhong Xin Pharmaceutical Group Corp.
August 21, 2020